Multimodal Approach to the Ontogenesis of Nociception in Very Preterm and Term Infants

Procedural Pain Clinical Trial

— NOCI-Prem  

Official title:

Multimodal Approach to the Ontogenesis of Nociception in Very Preterm and Term Infants

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05404594
• Other study ID #: 7256
• Status: Recruiting
• Phase: N/A
• Start date: July 17, 2019
• Est. completion date: April 17, 2023

Study information

• Verified date: January 2023
• Source: University Hospital, Strasbourg, France
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The management of pain related to venipuncture remains insufficient in very preterm infants (VPI. The separation between the mother (father) and her(his) child can aggravate the short-term painful experience of the newborn. Accurate diagnosis and treatment of pain is necessary to preserve the well-being and brain development of VPI. A better understanding of the development of pain pathways and the cortical integration of nociceptive messages is essential to reach this goal.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 80
• Est. completion date: April 17, 2023
• Est. primary completion date: April 17, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Experimental group: VPIs of gestational age less than or equal to 33 weeks on the day of birth and hospitalized in the neonatal intermediate care unit or the neonatal intensive care unit of the Neonatal department of the Hautepierre Hospital (Strasbourg University Hospital)

• Control group: Healthy full-term babies (> 37 weeks gestational age) hospitalized in the maternity ward of Strasbourg University Hospital

• Consent obtained from both parents

• Subject affiliated to a social health insurance plan.

Exclusion Criteria:

• - Any malformation known before inclusion

• Cerebral lesions discovered on cerebral ultrasound performed as part of the standard management of newborns (Intra-Ventricular Hemorrhages of grade III or IV of the Papile classification, Periventricular Leucomalacia)

• Unstable clinical status according to the investigator's judgment

• Expected transfer of the child to another hospital before the term of 40 weeks PMAs.

Related Conditions & MeSH terms

• Pain, Procedural
• Pre-Term
• Procedural Pain
• Venipuncture

Intervention

Behavioral:
• Maternal vocal contact
Two consecutive venipuncture (order randomly balanced) within a short period of time will be realized with and without the presence of the mother talking/singing to her VPI infant. In this intervention group, the mother will be supported to talk or to sing to her infants during before and during the venipuncture.

Locations

Country	Name	City	State
France	Service de Pédiatrie - Hôpital d'Hautepierre	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The cortical hemodynamic response profile	The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).	During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Primary	The cortical hemodynamic response profile	The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).	During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Primary	The cortical hemodynamic response profile	The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).	During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Primary	The cortical hemodynamic response profile	The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).	During a venipuncture at 2 to 3 days of life in term neonates
Secondary	Comparison of the hemodynamic response profiles and salivary oxytocin levels	Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies	During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Secondary	Comparison of the hemodynamic response profiles and salivary oxytocin levels	Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies	During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Secondary	Comparison of the hemodynamic response profiles and salivary oxytocin levels	Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies	During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Secondary	Comparison of the hemodynamic response profiles and salivary oxytocin levels	Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies	During a venipuncture at 2 to 3 days of life in term neonates
Secondary	Analysis of the impact on the responses of maternal separation	Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).	During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Secondary	Analysis of the impact on the responses of maternal separation	Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).	During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Secondary	Analysis of the impact on the responses of maternal separation	Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).	During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Secondary	Analysis of the impact on the responses of maternal separation	Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).	During a venipuncture at 2 to 3 days of life in term neonates
Secondary	Comparison of the response profiles according to the sex	Comparison of the response profiles obtained in females and males	During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Secondary	Comparison of the response profiles according to the sex	Comparison of the response profiles obtained in females and males	During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Secondary	Comparison of the response profiles according to the sex	Comparison of the response profiles obtained in females and males	During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Secondary	Comparison of the response profiles according to the sex	Comparison of the response profiles obtained in females and males	During a venipuncture at 2 to 3 days of life in term neonates
Secondary	Comparison of conduction velocities of small caliber nociceptive fibers	Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.	During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Secondary	Comparison of conduction velocities of small caliber nociceptive fibers	Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.	During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Secondary	Comparison of conduction velocities of small caliber nociceptive fibers	Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.	During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Secondary	Comparison of conduction velocities of small caliber nociceptive fibers	Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.	During a venipuncture at 2 to 3 days of life in term neonates
Secondary	Correlational analyses by APM group	Correlational analyses, by APM group, between the different pain indicators in response to stimulation	During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Secondary	Correlational analyses by APM group	Correlational analyses, by APM group, between the different pain indicators in response to stimulation	During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Secondary	Correlational analyses by APM group	Correlational analyses, by APM group, between the different pain indicators in response to stimulation	During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Secondary	Correlational analyses by APM group	Correlational analyses, by APM group, between the different pain indicators in response to stimulation	During a venipuncture at 2 to 3 days of life in term neonates
Secondary	Facial pain behavior	Facial pain behavior with the Neonatal Facial Coding System	During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Secondary	Facial pain behavior	Facial pain behavior with the Neonatal Facial Coding System	During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Secondary	Facial pain behavior	Facial pain behavior with the Neonatal Facial Coding System	During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Secondary	Facial pain behavior	Facial pain behavior with the Neonatal Facial Coding System	During a venipuncture at 2 to 3 days of life in term neonates
Secondary	Pain index	Pain index assessing the sympathetic and parasympathetic system	During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Secondary	Pain index	Pain index assessing the sympathetic and parasympathetic system	During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Secondary	Pain index	Pain index assessing the sympathetic and parasympathetic system	During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Secondary	Pain index	Pain index assessing the sympathetic and parasympathetic system	During a venipuncture at 2 to 3 days of life in term neonates
Secondary	Cortical evoked potentials	Cortical evoked potentials in Cz according to EEG 10:20 classification	During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Secondary	Cortical evoked potentials	Cortical evoked potentials in Cz according to EEG 10:20 classification	During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Secondary	Cortical evoked potentials	Cortical evoked potentials in Cz according to EEG 10:20 classification	During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Secondary	Cortical evoked potentials	Cortical evoked potentials in Cz according to EEG 10:20 classification	During a venipuncture at 2 to 3 days of life in term neonates